| Summary: | The misuse of prescription monitored drugs can lead to addiction, poisoning, and death of its consumers. In Canada, the rates of hospitalization due to opioid poisoning have increased by 27% over the past five years. On average, 17 hospitalizations per day occurred in 2017 due to an opioid-related poisoning and nearly 4,000 Canadians died from an apparent opioid-related overdose. Prescription (Drug) Monitoring Programs (PMPs/PDMPs) proactively collect and analyze information about prescription and dispensing of certain monitored drugs. In Canada, some of the main objectives of PMPs are to enhance patient care and assist in the safe use of controlled prescription drugs by monitoring outpatient prescription dispensing information, to help reduce the harms resulting from the use of controlled prescription drugs, and to assist in reducing the diversion of controlled prescription drugs. This report is to summarize the clinical evidence regarding the safety of PMPs and evidence-based guidelines informing the use of PMPs for optimizing medication use and preventing harm
|
|---|